15 July 2020>: Clinical Research
Radiofrequency Ablation (RFA) Combined with Transcatheter Arterial Chemoembolization (TACE) for Patients with Medium-to-Large Hepatocellular Carcinoma: A Retrospective Analysis of Long-Term Outcome
Weiwen Liu 1ABC , Huihong Xu 2DE , Xihui Ying 1EFG , Dengke Zhang 1CD , Linqiang Lai 1BC , Linyou Wang 3EF , Jianfei Tu 1CFG* , Jiansong Ji 1BDG*DOI: 10.12659/MSM.923263
Med Sci Monit 2020; 26:e923263
Figure 8 Patients with ≤40 U/L AST had longer 1-, 2-, 3-, 5-, and 6-year survival rates compared with those with AST >40 U/L (87.3% vs. 67.1%, 71.5% vs. 46.5%, 49.4% vs. 26.5%, 23.0% vs. 11.8%, and 15.4% vs. 0%.